Latest stories on PHAT
Phathom Pharmaceuticals Non-GAAP EPS of $0.00 beats by $0.10, revenue of $74.27M beats by $1.58M
Seeking Alpha68 · bullishearnings
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | PHAT Stock News
StockTitan50 · neutralgeneral
Phathom Completes Enrollment in Eosinophilic Esophagitis Trial
TipRanks63 · neutralproduct/pr
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals, Inc. (PHAT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Phathom: Why I'm Downgrading To "Sell" Ahead Of Competition
Seeking Alpha32 · bearishanalyst
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences | PHAT Stock News
StockTitan56 · neutralgeneral
Phathom Shareholders Reaffirm Board, Pay and Auditor
TipRanks50 · neutralgeneral